KP Tissue Inc. (TSE:KPT - Get Free Report) shares hit a new 52-week high during trading on Tuesday . The stock traded as high as C$9.34 and last traded at C$9.40, with a volume of 67161 shares changing hands. The stock had previously closed at C$9.19.
Wall Street Analysts Forecast Growth
KPT has been the topic of several research analyst reports. National Bankshares raised their price objective on KP Tissue from C$8.50 to C$9.50 and gave the company a "sector perform" rating in a report on Thursday, May 22nd. Desjardins raised their price objective on KP Tissue from C$8.50 to C$9.50 and gave the company a "hold" rating in a report on Thursday, May 22nd. Finally, TD Securities raised their price objective on KP Tissue from C$8.00 to C$9.00 and gave the company a "hold" rating in a report on Thursday, May 22nd.
Check Out Our Latest Research Report on KPT
KP Tissue Stock Up 0.2%
The firm has a market cap of C$94.45 million, a PE ratio of 14.80, a P/E/G ratio of -0.88 and a beta of 0.37. The firm has a 50-day moving average price of C$9.09 and a two-hundred day moving average price of C$8.45.
KP Tissue Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 15th were given a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 7.6%. The ex-dividend date was Monday, June 30th. KP Tissue's dividend payout ratio (DPR) is 112.73%.
KP Tissue Company Profile
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Further Reading
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access